News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1334
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => f1faa4a7ec1c5b42020d.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-07-03
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-07-03 10:14:20
            [updated_time] => 2025-07-25 08:53:35
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-to-present-oral-report-at-ESHRE-2025-with-Research-on-segmental-mosaic-embryo-transfer
            [title] => GENTIS to Present Oral Report at ESHRE 2025 with Research on Segmental Mosaic Embryo Transfer
            [description] => A scientific study conducted by GENTIS, in collaboration with experts from Genoma and several other institutions in Vietnam and around the world, has been selected for an oral presentation at the ESHRE 2025 conference.
            [content] => 
ESHRE – The World’s Leading Annual Event in Reproductive Medicine
 ESHRE (European Society of Human Reproduction and Embryology) is the largest international conference in the field of reproductive medicine and embryology. Held annually in July by the European Society of Human Reproduction and Embryology, the event brings together thousands of experts, researchers, physicians, and global health organizations to share knowledge, research findings, and the latest trends in the treatment of infertility.

In 2025, the ESHRE conference will take place at the Paris Convention Centre – Porte de Versailles, one of the most modern and largest venues in Europe, from June 29 to July 2, 2025. This is a valuable opportunity for healthcare professionals to update their knowledge, expand professional networks, and jointly advance the field of reproductive medicine – a domain deeply rooted in human compassion and care.
GENTIS Research on Segmental Mosaic Embryos Selected for Oral Presentation
GENTIS is honored to have its research project titled: “Decoding the clinical fate of segmental mosaic embryos: key predictors of implantation and pregnancy success”
 (selected Vietnamese title: "Giải mã kết cục lâm sàng chuyển phôi khảm cấu trúc một phần: các yếu tố chủ đạo dự đoán sự thành công chuyển phôi và mang thai IVF")
 chosen by the ESHRE Scientific Committee for oral presentation – the highest and most prestigious form of presentation at the conference.
The Study Focuses on Segmental Mosaic Embryos – A Promising Yet Controversial Path in IVF
The research centers on segmental mosaic embryos – a type of embryo containing both normal and abnormal cells due to errors in mitotic cell division. The use of such embryos in IVF has long been controversial, yet it presents a promising option when no euploid embryos (chromosomally normal) are available.
The main objective of the study is to evaluate the implantation potential, pregnancy outcomes, and live birth rates of segmental mosaic embryos, thereby identifying key predictors of clinical success and proposing safer embryo selection criteria for IVF practice.

Data and Research Methods
 This is a retrospective study, analyzing data from 3,790 mosaic embryos recorded in the International Registry of Mosaic Embryo Transfers (IRMET) between 2017 and 2024. The methodology includes:

Embryo classification:


Segmental mosaic embryos: 1,567

Whole-chromosome mosaic embryos: 1,723

Euploid embryos: 19,258



Embryo characteristics:


Degree of mosaicism (percentage of abnormal cells)

Type of abnormality (segmental deletion or duplication)

Size of the affected chromosomal segment

Embryo morphology (Inner Cell Mass – ICM, and Trophectoderm – TE)

Timing of biopsy (Day 4–6)



Clinical outcomes analyzed:


Implantation rate

Clinical pregnancy rate

Live birth rate

Miscarriage rate



Statistical methods:


Logistic regression analysis

Chi-square tests

Standardized sequencing platform for consistent results




Key Findings
 The study revealed several important factors that directly influence the clinical success of mosaic embryo transfer, including:

The ongoing pregnancy rate (OPR) for segmental mosaic embryos was 45.5%, higher than whole-chromosome mosaics (34.3%) but lower than euploid embryos (50%).


Higher levels of mosaicism significantly reduced OPR:


50% success at 20% mosaicism

45% at 30–40%

Only 27% at 60%



Embryos with small deletions, particularly on short chromosomal arms, showed higher success rates compared to large deletions or duplications.


Timing of biopsy strongly affected outcomes: biopsies done on Day 4–5 yielded better results than those on Days 5 or 6.


Embryos with high-quality morphology (ICM and TE) achieved superior clinical outcomes.



These findings emphasize that embryo selection for mosaic transfer should be based on multiple integrated criteria, rather than solely relying on classification from PGT-A (Preimplantation Genetic Testing for Aneuploidy).
Significance and Contributions of the Study
 This research represents the first large-scale dataset on segmental mosaic embryos, with contributions from 20 IVF centers worldwide. Its practical impact includes:

Enhancing clinical understanding of mosaic embryo behavior


Supporting more informed and optimized embryo selection


Contributing to the standardization of PGT-A reporting criteria, ultimately improving the safety and effectiveness of mosaic embryo transfer



This study also marks an important milestone for GENTIS, showcasing its commitment to rigorous scientific research, alignment with global trends, and its mission to accompany patients on their journey through infertility treatment.
Being selected for an oral presentation at ESHRE 2025 is a proud achievement, not only for GENTIS but for Vietnam’s entire reproductive medicine community. We firmly believe that our continued efforts in research and innovation will enhance IVF success rates and expand the possibility of parenthood for millions of families around the world.

            [content_more] => 
            [meta_title] => GENTIS to Present Oral Report at ESHRE 2025 with Research on Segmental Mosaic Embryo Transfer
            [meta_description] => A scientific study conducted by GENTIS, in collaboration with experts from Genoma and several other institutions in Vietnam and around the world, has been selected for an oral presentation at the ESHRE 2025 conference. This marks a significant milestone, 
            [meta_keyword] => GENTIS,ESHRE
            [thumbnail_alt] => 
            [post_id] => 1334
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1333
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => b45ce3cee13e56600f2f.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-06-28
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-28 09:57:48
            [updated_time] => 2025-07-25 09:08:40
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => GENTIS-joins-the-2025-national-conference-on-medical-genetics-as-an-official-sponsor
            [title] => GENTIS Joins the 2025 National Conference on Medical Genetics as an Official Sponsor
            [description] => Continuing its mission to support the medical community in advancing genomic medicine in Vietnam, GENTIS is honored to participate in the 2025 National Conference on Medical Genetics as an official sponsor. This annual, nationwide scientific event brings together leading experts, scientists, physicians, and professionals in the field of genetics.
            [content] => 



Date: July 4–5, 2025


Venue: Thanh Hoa Campus – Hanoi Medical University


A Focus on the Latest Advances in Genomic Medicine
This year’s conference highlights cutting-edge advancements in genomic medicine, offering a diverse and in-depth academic program. The sessions and discussions will revolve around five key topics:


Indications and genetic testing before and during pregnancy


Applications of genomic medicine in cancer diagnosis and treatment


Genomic interpretation – from genotype to phenotype


Infertility and assisted reproductive technologies (ART)


Updates on treatment progress for genetic disorders


The conference targets a professional audience, including clinical specialists, physicians, researchers, laboratory technicians, and healthcare professionals working in: clinical genetics, genetic counseling, molecular biology, cell biology, precision medicine, and medical diagnostics.
GENTIS – A Pioneer in Genetic Testing, Advancing Genomic Medicine in Vietnam
At the 2025 National Conference on Medical Genetics, GENTIS will not only showcase its genetic testing solutions applied in clinical practice, but will also contribute academically through valuable scientific presentations delivered by the company’s R&D team.
GENTIS Highlights at the Conference:


Product & Service Exhibition Booth


Showcasing modern genetic and genomic testing services for prenatal screening and diagnosis, reproductive health, oncology, and inherited diseases


Professional exchanges with doctors and industry experts


Interactive minigames with exciting gifts for attendees




Key Scientific Reports by GENTIS
Oral Presentations:


Mr. Nguyen Van Huynh, MSc – Head of R&D, GENTIS:
 "Detection of Balanced Translocations in Preimplantation Embryos Using PGT Technology"


Dr. Đinh Thi Quynh Ngoc, MSc, MD – R&D Specialist, GENTIS:
 "Development of Interpretation Software for Newborn Screening Results via LC-based Methodology"


Poster Presentation:


Dr. Vu Thu Hương, MSc, MD & Dr. Pham Dinh Minh – R&D, GENTIS:
 "Application of Expanded Carrier Screening and PGT-M for Thalassemia in Assisted Reproduction Centers in Vietnam – Potential, Limitations, and Guideline-Based Approaches"




Affirming GENTIS’s Leadership in Genetic Testing
Through its participation in the 2025 National Conference on Medical Genetics, GENTIS continues to affirm its pioneering role in the research, development, and application of genetic testing in Vietnam. We are committed to providing modern, accurate, and highly personalized testing solutions that effectively support the screening, diagnosis, and treatment of genetic conditions.
GENTIS warmly invites all physicians and delegates to visit our booth at the conference to share knowledge, experience new technologies, and explore collaborative opportunities in the field of genetics.
            [content_more] => 
            [meta_title] => GENTIS Joins the 2025 National Conference on Medical Genetics as an Official Sponsor
            [meta_description] => Continuing its mission to support the medical community in advancing genomic medicine in Vietnam, GENTIS is honored to participate in the 2025 National Conference on Medical Genetics as an official sponsor.
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1333
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1332
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z6723330422103_a36164bfd599ec7f26bedc31b939276c.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-06-24
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-24 09:38:28
            [updated_time] => 2025-07-24 14:40:35
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => cap-certification-the-international-gold-standard-for-laboratory-quality
            [title] => CAP Certification – The International Gold Standard for Laboratory Quality
            [description] => n modern medicine, laboratory testing is no longer just a supplementary tool but a critical factor in diagnosing and treating patients. However, a common misconception is that the quality of laboratory tests mainly depends on advanced equipment, test kits, or highly skilled technicians — as many facilities currently promote.
            [content] => 









In reality, no single factor can guarantee accurate test results without being part of a comprehensive quality management system. Every stage — from sample collection and processing to analysis and reporting — must operate in a synchronized, controlled, and traceable manner. This system is the true foundation that ensures test results are accurate, consistent, and reliable. This is especially crucial in the field of genetic testing, where even the smallest error can lead to serious consequences for the patient, making a tightly managed system an absolute necessity.
True Quality Comes from a Structured and Unified Operational System

Dr. Nguyen Quang Vinh – Director, GENTIS Laboratory Center
Test results are not simply the output of machines or test kits; they are the outcome of a complex, interconnected process — from input sample evaluation and standardized analysis protocols (PCR, sequencing, NGS), to internationally-aligned data interpretation and practical clinical reporting. Every step serves as a quality control checkpoint, and a single mistake can have serious implications for diagnosis and treatment.
Furthermore, laboratory quality is enhanced through the diversity of equipment and the application of advanced technologies that effectively handle the wide range of complexities in modern medicine. Relying on a single technology, test kit, or device is an outdated approach and no longer suitable for building a high-quality testing system.
Establishing a comprehensive quality management system not only minimizes risks but also fosters strong trust among laboratories, physicians, and patients. When processes are tightly controlled, results are accurate, consistent, and traceable — key criteria that physicians rely on for treatment decisions and that give patients confidence in their test outcomes.
CAP – The Gold Standard in Laboratory Quality Management
Dr. Pham Dinh Minh – Director of R&D, GENTIS (Left) with CAP Representative at GENTIS Laboratory
The CAP (College of American Pathologists) certification is recognized globally as the gold standard in clinical laboratory quality. To earn this certification, laboratories must meet stringent requirements and establish a comprehensive quality management system aligned with international standards. This includes participation in regular external quality assessments, expert evaluations, complete data traceability, and continuous quality improvement.
The CAP standard does not assess equipment or personnel in isolation, but evaluates the entire laboratory operation. Everything from standard operating procedures, sample control, technical performance validation, result analysis, to traceability and incident handling — all must meet the highest benchmarks. As a result, a CAP-certified quality system ensures high accuracy, complete transparency, and maximum patient safety.
Another advantage of CAP certification is its support in effectively applying ISO standards in Vietnam by supplementing them with specialized technical requirements. The integration of CAP with ISO 15189 creates a comprehensive framework that enhances both operational efficiency and technical quality. Vietnamese laboratories achieving CAP certification not only meet global standards but also improve practical operations and result accuracy.
“CAP standards bring tangible value to many stakeholders. For doctors, CAP certification is a key factor that ensures confidence in test accuracy, helping them personalize treatment plans, shorten diagnosis time, and reduce retesting — saving time and cost for patients. For customers, testing at a CAP-certified lab means access to a modern, reliable, internationally compatible system — especially beneficial for patients seeking treatment abroad, as results are widely recognized without the need for retesting. High-quality results also reduce errors and enhance peace of mind in healthcare. In addition, partners working with CAP-certified labs like Gentis gain opportunities for sample exchange, data sharing, clinical research, and providing international-standard services, expanding collaboration and development in the medical field,” shared Dr. Pham Dinh Minh (Director of CAP Laboratory, Gentis - Eurofins).
Gentis – Differentiated by CAP-Standard Quality System

Dr. Tar-Choon Aw – Laboratory Director, Changi General Hospital, CAP Expert (Far Right) working with GENTIS experts
In Vietnam, Gentis is one of the pioneers in building a high-quality genetic testing system that meets international standards. Achieving CAP certification is not just a testament to the continuous commitment to quality improvement, but also affirms Gentis’s unique position in applying a globally standardized quality management system for genetic testing in Vietnam.
While many facilities focus their messaging on technology, equipment, test kits, or technician expertise, Gentis understands that true quality comes from a complete quality management system. A systematic and consistent framework is the key to ensuring trustworthy results. Gentis not only invests in modern equipment but also establishes a tightly controlled quality chain — from sample collection and processing to result reporting. All testing data at Gentis is stored, traceable, and controlled according to ISO standards, and strictly complies with CAP certification requirements.
“When doctors receive test results from Gentis, they’re not just getting a number — they’re receiving an internationally certified result backed by a rigorous quality system. This is what fundamentally sets Gentis apart from units that only invest in technology or technician training. Test quality cannot stem from a single factor — it must be the outcome of a cohesive, tightly controlled system,” emphasized Dr. Pham Dinh Minh
With its CAP certification, Gentis affirms its commitment to quality — not merely in words but through concrete action — serving as clear evidence of its sustainable and truly differentiated path in the field of genetic testing in Vietnam.











            [content_more] => 
            [meta_title] => CAP Certification – The International Gold Standard for Laboratory Quality
            [meta_description] => n modern medicine, laboratory testing is no longer just a supplementary tool but a critical factor in diagnosing and treating patients. However, a common misconception is that the quality of laboratory tests mainly depends on advanced equipment, test kits
            [meta_keyword] => GENTIS,CAP
            [thumbnail_alt] => 
            [post_id] => 1332
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1327
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => image2.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-06-16
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-16 09:18:37
            [updated_time] => 2025-07-24 14:39:20
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => cap-standards-and-experience-in-building-a-laboratory
            [title] => CAP Standards and Experience in Building a Laboratory
            [description] => Two guest experts at the talk show themed “CAP Standards and Experience in Building a Laboratory” were Prof. Dr. Tran Duc Phan - Chairman of the Vietnam Society of Medical Genetics and Dr. Pham Dinh Minh - Director of R&D at GENTIS.

In modern medical testing, especially in the field of genetics, quality management plays a crucial role in ensuring the accuracy and reliability of results. The CAP (College of American Pathologists) standard is one of the strictest quality management systems today, requiring meticulous control from sample collection to analysis and result reporting. Applying CAP standards helps improve professional capacity, standardize testing procedures, minimize errors, and increase the internationalization of results, bringing tangible benefits to both clinical doctors and patients.
            [content] => 

Two guest experts at the talk show themed "CAP Standards and Experience in Building a Laboratory" were Prof. Dr. Tran Duc Phan - Chairman of the Vietnam Society of Medical Genetics and Dr. Pham Dinh Minh - Director of R&D at GENTIS.









Quality Management - The Foundation for Accurate Testing
 Quality management in medical testing plays an essential role in ensuring accurate results for patients. This process not only guarantees the output quality but also includes a strict control and processing system from sample collection, preservation, analysis, to result reporting and consultation. In genetic testing, the importance of quality management becomes even more vital. Prof. Dr. Tran Duc Phan - Chairman of the Vietnam Society of Medical Genetics shared: “This is a field where even a small mistake in the process can lead to serious consequences, not just for the individual patient but also for their family. Unlike other tests that can vary depending on physical condition or timing, genetic information is immutable—meaning a wrong result can lead to a cascade of errors in consultation, diagnosis, or future treatment directions. Therefore, building a comprehensive quality management system not only helps minimize errors but also lays the foundation to build trust between the laboratory, treating doctors, and patients. A laboratory system controlled from input to output ensures accuracy, consistency, and traceability. These are core factors to support effective treatment and ensure patient safety.”
The Role and Benefits of CAP Standards
 Among the quality management systems currently applied, CAP standards stand out due to their level of detail and depth, especially in genetics and molecular biology. Established and managed by the College of American Pathologists (USA), CAP is recognized as one of the strictest standards today, requiring synchronized control of equipment, operational processes, personnel capacity, and result quality. Dr. Pham Dinh Minh (Director of R&D at GENTIS - one of the genetic testing units certified by CAP) shared: “CAP standards not only focus on technical criteria but also require laboratories to build an effective internal quality control system (IQCP) and regularly participate in external quality control with international organizations. For genetic tests, this standard covers every stage: from sample collection and quality control to analysis, interpretation, and clinical reporting. These are essential requirements for genetic testing, where accuracy must be maintained absolutely and results need to reach the highest reliability. Achieving CAP certification means the laboratory can provide internationally recognized results, accepted in countries that apply equivalent standards. This not only enhances professional credibility but also expands the opportunities for international collaboration, sample exchange, and data sharing with foreign healthcare entities.”
The Journey of Building and Achieving CAP Certification
 Sharing about the process of achieving CAP certification, Dr. Minh mentioned that it was not an easy journey. In Vietnam, several units have pioneered pursuing this standard and achieved impressive results after a preparation period of more than 18 months. During this period, laboratories had to re-establish their entire internal control process according to the IQCP model and participate in regular external quality control as per CAP’s prescribed frequency. All operational processes, technical documentation, and test data had to be standardized according to CAP requirements. It wasn’t just about investing in equipment and infrastructure; the key factor in this journey was the people. CAP requires laboratories to have a highly skilled workforce, especially genetic counselors and genetic doctors who can analyze data and provide accurate advice to treating doctors. Additionally, since the entire system works and communicates with CAP using specialized English, language proficiency became a significant obstacle, requiring key personnel to receive proper training and continuously update their knowledge - Dr. Pham Dinh Minh shared his practical experiences in GENTIS’s journey to CAP certification. The final result was an internationally certified testing system with tight risk control, efficient operation, transparency, and readiness to integrate into the global healthcare ecosystem. “After achieving CAP certification, GENTIS has had the opportunity to work with other CAP-certified laboratories from Japan, Singapore, and Malaysia. This expands collaboration opportunities and enhances Vietnam’s position on the regional and global map,” Dr. Minh shared.
What Benefits Do Partners and Clients Gain?
 CAP standards create practical and direct value for stakeholders, especially clinical doctors, patients, and domestic and international medical partners. Prof. Dr. Tran Duc Phan shared: “For doctors, CAP provides trust in the test results—a crucial foundation for making accurate treatment decisions, personalizing protocols, and shortening the diagnosis time. When the results are highly reliable, doctors will reduce the need for retesting, saving time and costs for patients. For service users, being tested in a CAP-certified laboratory means they are accessing a standardized, reliable testing system with international compatibility. This is particularly meaningful for patients planning treatment abroad, as results from CAP-certified laboratories are often accepted in many countries without the need to retest. Furthermore, high quality also means a reduced risk of treatment errors, minimized additional costs, and enhanced peace of mind throughout the healthcare process.” In addition to doctors and patients, partners collaborating with CAP-certified laboratories also benefit: “For partners, collaborating with a CAP-certified laboratory like GENTIS opens up the possibility of data exchange, sample sharing, conducting clinical research, or providing testing services according to international standards,” Dr. Pham Dinh Minh added.
CAP standards are not only a quality evaluation system but also a strategic tool that enhances professional reputation, expands international collaboration opportunities, and—most importantly—creates real value for patients, doctors, and the entire healthcare system. In the current trend of integration and precision medicine, building a CAP-certified laboratory is a significant step forward, affirming the position of Vietnamese healthcare on the international stage.









            [content_more] => 
            [meta_title] => CAP Standards and Experience in Building a Laboratory
            [meta_description] => Two guest experts at the talk show themed “CAP Standards and Experience in Building a Laboratory” were Prof. Dr. Tran Duc Phan - Chairman of the Vietnam Society of Medical Genetics and Dr. Pham Dinh Minh - Director of R&D at GENTIS.
            [meta_keyword] => GENTIS,CAP
            [thumbnail_alt] => 
            [post_id] => 1327
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1326
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => dsc08818.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-06-16
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-16 09:04:32
            [updated_time] => 2025-07-24 15:57:46
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => GENTIS-the-first-unit-in-vietnam-to-achieve-CAP-certification-for-PGT-and-NIPT-testing
            [title] => GENTIS - The Unit in Vietnam to Achieve CAP Certification for PGT and NIPT Testing
            [description] => On June 12, 2025, GENTIS Genetic Testing Center officially became the unit in Vietnam to achieve CAP (College of American Pathologists) certification for two tests: PGT (Pre-implantation Genetic Testing) and NIPT (Non-Invasive Prenatal Testing).

This marks an important milestone in GENTIS's 15-year journey of continuous efforts to improve the quality of genetic testing services, contributing to the physical and mental health protection of the Vietnamese people.
            [content] => 
CAP Certification - A Milestone Affirming GENTIS's Commitment to Quality and Testing Safety
 Founded in 2010, GENTIS quickly established itself as one of the most reputable genetic testing centers in Vietnam. Over the past 15 years, GENTIS has not only provided high-quality testing services but also pioneered the application of the latest technology in the field of genetics.
With a goal of protecting public health, GENTIS has always focused on applying international standards, especially in reproductive health services and prenatal screening. GENTIS’s success is not only the result of substantial investment in technology and modern infrastructure but also the continuous efforts of a team of highly trained, experienced experts.
Achieving CAP certification for the laboratories performing PGT and NIPT is a clear testament to GENTIS’s strong commitment to improving the quality of testing, safeguarding the health of the population, and contributing to the development of Vietnam's healthcare sector. The CAP certification is one of the most prestigious international accreditations that laboratories can obtain.
Mr. Tran Van Khoi, Director of LAQAS (Laboratory Quality Assurance Services), the representative and distributor of CAP in Vietnam, congratulated GENTIS on this outstanding achievement.
CAP is considered the "gold standard" in laboratory testing, with a strict evaluation system covering sample collection, processing, analysis, quality control, data security, and result storage. GENTIS meeting all these requirements clearly demonstrates its operational capacity, quality control, and reliability in each test result provided.
CAP certification is the result of a long process of rigorous testing and assessment of quality standards, and GENTIS’s achievement of this certification is a testament to its commitment to continuously improving the quality of testing and healthcare services. Especially in the context of society placing increasing importance on quality of life and health, the CAP certification further confirms that GENTIS is on the right track in providing advanced and safe services to the community.
Achieving CAP certification not only expands GENTIS’s credibility and influence domestically but also serves as a critical step towards connecting and collaborating with international partners in fields such as technology transfer, scientific research, and specialized training. GENTIS is not merely a testing center; it is gradually becoming a bridge to integrate Vietnam’s genetics field more deeply into the global landscape, contributing to improving the quality of the nation’s gene pool and building a healthier future generation.
Commitment to Enhancing the Physical and Intellectual Health of the Community

 CAP Certification - A Milestone Affirming GENTIS's Commitment to Enhancing the Physical and Mental Health of the Vietnamese People

 Being recognized by CAP for PGT and NIPT testing is not only a testament to the tireless efforts of the team but also a commitment by GENTIS to its mission: “Enhancing the Physical and Intellectual Health of the Vietnamese People.” This reflects its commitment to always providing accurate, safe, and confidential genetic testing services at the highest level. Each test result at GENTIS is carried out under the close supervision of experts, with standardized procedures and advanced technology.
Furthermore, GENTIS is committed to continuing investments in infrastructure, technology, and expert teams, gradually establishing itself as a pioneer in genetic testing. The CAP certification is not the final goal, but rather the beginning of a more in-depth and sustainable development phase. GENTIS will continue to strive to provide high-quality genetic healthcare services, ensuring the health of millions of Vietnamese families.
            [content_more] => 
            [meta_title] => GENTIS - The Unit in Vietnam to Achieve CAP Certification for PGT and NIPT Testing
            [meta_description] => On June 12, 2025, GENTIS Genetic Testing Center officially became the  unit in Vietnam to achieve CAP (College of American Pathologists) certification for two tests: PGT and NIPT.
            [meta_keyword] => GENTIS,CAP
            [thumbnail_alt] => 
            [post_id] => 1326
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1321
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => dsc08805.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-06-12
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-13 08:42:53
            [updated_time] => 2025-06-16 14:22:29
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => GENTIS-The-pioneer-in-Vietnam-to-achieve-CAP-certification-for-PGT-and-NIPT-genetic-testing
            [title] => GENTIS – The Pioneer in Vietnam to Achieve CAP Certification for PGT and NIPT Genetic Testing
            [description] => On June 11, 2025, GENTIS proudly hosted a ceremony to receive the CAP (College of American Pathologists) Certification for PGT (Preimplantation Genetic Testing) and NIPT (Non-Invasive Prenatal Testing).
            [content] => 









With this event, GENTIS officially became the first unit in Vietnam to be internationally recognized by CAP for both PGT and NIPT genetic tests, affirming its pioneering position and exceptional expertise in the field of genetic testing.
The ceremony was attended by Mr. Tran Van Khoi, Director of the Laboratory Quality Assurance Science Joint Stock Company (LAQAS), the official representative and distributor of CAP in Vietnam. Representatives from GENTIS included Mr. Đỗ Mạnh Hà, CEO, along with members of the leadership team and experienced specialists.
GENTIS held the solemn ceremony to receive the CAP Certification for PGT and NIPT tests, marking an important milestone confirming international standards.
CAP Certification – A Global Benchmark
CAP is a prestigious global certification issued by the American Society for Pathology, a world leader in laboratory quality control. To achieve this certification, institutions must meet over 800 strict evaluation criteria, including technical infrastructure, quality control systems, analysis processes, and professional team competence.
This is the first time that a genetic institution in Vietnam has been awarded CAP certification for PGT and NIPT – two techniques that require extremely high precision, advanced technology, and strict process compliance. Achieving CAP certification for both tests confirms that GENTIS's laboratory system meets international standards in equipment, operational procedures, and professional competence.
Mr. Tran Van Khoi, Director of LAQAS, presented flowers and the CAP certificate to Mr. Phạm Đình Minh, Director of the CAP GENTIS Laboratory.
This milestone firmly establishes GENTIS’s professional competence and test quality, matching the standards of leading laboratories worldwide.
GENTIS – A Leader in Genetic Testing for Reproductive Health
The CAP certification ceremony was attended by Mr. Trần Văn Khôi, Director of LAQAS, the official representative and distributor of CAP in Vietnam, Mr. Đỗ Mạnh Hà, CEO of GENTIS, and members of the leadership team and genetic experts from the company.
In his speech, Mr. Tran Van Khoi praised GENTIS’s efforts in investing in technology and quality systems: “GENTIS’s CAP certification demonstrates the company’s serious investment in improving testing quality management. This not only proves GENTIS’s high professional competence in test results but also shows their efforts and commitment to quality management to deliver highly accurate, reliable results to patients and doctors.”
Mr. Do Manh Ha(CEO of GENTIS) shared about the journey of taking GENTIS from its pioneering beginnings to an internationally accredited laboratory.
Mr. Do Manh Ha, CEO of GENTIS, emphasized: “Achieving CAP certification is the result of many years of persistence in building an internationally recognized system. We are committed to continuing to accompany our customers and partners in the healthcare journey with high-quality, accurate, safe, and humane genetic services.”
Meeting the Growing Demand in Reproductive Health Care
With the trend towards personalized medicine and the increasing demand for prenatal screening, diagnosis, and reproductive support, the implementation of internationally certified PGT and NIPT services in Vietnam is highly meaningful:


PGT assists in genetic screening of embryos during the in vitro fertilization (IVF) process, helping to select healthy embryos, increase the success rate, and reduce the risk of genetic diseases.


NIPT helps detect chromosomal abnormalities in the fetus as early as the 10th week of pregnancy, using only a blood sample from the mother, with no invasiveness, high safety, and accuracy.


PGT and NIPT are two tests that require advanced technology, specialized knowledge, and strict quality control processes – factors that GENTIS has developed and perfected over the years. The achievement of CAP certification for these two important genetic tests is a significant event, marking a major step forward in standardizing and elevating the quality of genetic testing services in Vietnam to international standards.
Commitment to Sustainable Development and Expanding International Collaboration
During the ceremony, Mr. Do Manh Ha, CEO of GENTIS, affirmed:
“Receiving the CAP certification is an important milestone not only for GENTIS but also for the genetic testing industry in Vietnam. We are committed to continuing to invest in technology, enhance our team’s expertise, and constantly improve processes to provide accurate, safe, and humane testing services to the community.”
GENTIS is currently one of the pioneers in the field of genetic testing in Vietnam, with 15 years of development, serving millions of customers with laboratories certified to international standards including CAP, ISO 15189:2022, ISO 27001:2022, and ISO 9001:2015. The CAP certification demonstrates the strong development potential and international integration capacity of Vietnam’s biomedical industry.










            [content_more] => 
            [meta_title] => GENTIS – The Pioneer in Vietnam to Achieve CAP Certification for PGT and NIPT Genetic Testing
            [meta_description] => On June 11, 2025, GENTIS proudly hosted a ceremony to receive the CAP (College of American Pathologists) Certification for PGT (Preimplantation Genetic Testing) and NIPT (Non-Invasive Prenatal Testing).
            [meta_keyword] => GENTIS,CAP
            [thumbnail_alt] => 
            [post_id] => 1321
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1319
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => img_0334.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-06-09
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-09 14:10:21
            [updated_time] => 2025-06-16 14:27:58
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => GENTIS-accompanies-Hai-Phong-International-Obstetrics-and-Pediatrics-Hospital-in-the-Ceremony-Celebrating-1000-babies-born-from-the-IVF-center
            [title] => GENTIS Accompanies Hai Phong International Obstetrics and Pediatrics Hospital in the Ceremony Celebrating "1,000 Babies Born from the IVF Center"
            [description] => On June 8, 2025, GENTIS had the honor of accompanying Hai Phong International Obstetrics and Pediatrics Hospital in the meaningful event: the ceremony celebrating “Welcoming 1,000 Little Angels Born from the IVF Center.” This milestone marks a significant achievement for the IVF Center in realizing the dream of parenthood for thousands of families.
            [content] => 









The ceremony was attended by Professor, Doctor, Labor Hero, People’s Teacher Nguyễn Viết Tiến – Chairman of the Vietnam Obstetrics and Gynecology Association, former Deputy Minister of Health, former Director of the Central Obstetrics and Gynecology Hospital, Director of Thiện An Hospital. Also present were Dr. Hà Anh Đức – Director of the Department of Medical Examination and Treatment (Ministry of Health), ThS. Đinh Anh Tuấn – Director of the Department of Maternal and Child Protection, PGS.TS. Lê Minh Quang – Director of Hai Phong Department of Health, along with representatives from various departments, agencies, and numerous partners and businesses who have accompanied the hospital throughout its journey.

The presence of leading experts and high-level leaders is evidence of the healthcare sector’s recognition and appreciation of Hai Phong International Obstetrics and Pediatrics Hospital’s efforts and contributions to reproductive support – a field that requires deep expertise, advanced technology, and unwavering commitment to patients.
The Reproductive Support Center – IVF at Hai Phong International Obstetrics and Pediatrics Hospital was established with the mission to provide an opportunity for parenthood to thousands of infertile and couples facing difficulties in conceiving. After years of development, the Center has welcomed 1,000 babies born through IVF, serving as a vivid testament to the professionalism, dedication of the medical staff, and the trust of families.
In their speech at the ceremony, the hospital’s leadership emphasized: “Each child born is a miracle, a culmination of modern medicine, love, and perseverance. We are proud to have written this journey of love together with families, with our hearts, responsibility, and trust.”

The ceremony also provided the hospital with an opportunity to express their sincere gratitude to healthcare leaders, leading experts, collaborating units, and especially the families of patients who have trusted and chosen the IVF Center at Hai Phong Hospital in their pursuit of happiness.
During the event, many touching stories were shared – journeys of overcoming difficulties, hope, and tears, culminating in the overwhelming joy of hearing the first cries of their children. These families, once despairing because of infertility, are now living proof of the power of modern medicine and the compassion of healthcare providers.
With a team of experienced doctors, modern equipment, and support from leading experts both domestically and internationally, the IVF Center at Hai Phong International Obstetrics and Pediatrics Hospital is increasingly establishing itself as one of the top reputable addresses for reproductive support in the North.
As the hospital enters a new stage of development, it will continue to invest in expertise, upgrade technology, expand international collaborations, and continuously improve service quality to bring more trust and happiness to an increasing number of families.
The ceremony marking the birth of 1,000 IVF babies is not only a source of pride but also a commitment to continue “planting seeds of life,” accompanying the unfinished dreams of parenthood. A new journey is opening, continuing the miracles born from love and modern medicine.

As a strategic partner in genetic testing for reproductive support, GENTIS is committed to accompanying healthcare facilities in enhancing the quality of infertility and reproductive care in Vietnam. During the event, GENTIS provided expert information on:


Preimplantation Genetic Testing (PGT)


Genetic counseling for IVF support


Screening tests before and during pregnancy


Early detection of genetic abnormalities in newborns


Through advanced technologies, GENTIS aims to work alongside doctors and medical experts to improve the success rate of IVF and ensure the birth of healthy, well-developed babies.
The event served as a time for healthcare professionals, families, and partners to reflect on the emotional and meaningful journey – a place where medical trust and the application of modern genetic technology converge, giving wings to thousands of happiness stories. GENTIS extends its congratulations to the IVF Center at Hai Phong International Obstetrics and Pediatrics Hospital and hopes to continue accompanying healthcare facilities in the mission of providing comprehensive, effective, and humane reproductive health care.










            [content_more] => 
            [meta_title] => GENTIS Accompanies Hai Phong International Obstetrics and Pediatrics Hospital in the Ceremony Celebr
            [meta_description] => On June 8, 2025, GENTIS had the honor of accompanying Hai Phong International Obstetrics and Pediatrics Hospital in the meaningful event: the ceremony celebrating “Welcoming 1,000 Little Angels Born from the IVF Center.” 
            [meta_keyword] => GENTIS,Baby
            [thumbnail_alt] => 
            [post_id] => 1319
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1317
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 502585524_1119643676865800_2310105009568831395_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-06-06
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-06-02 10:30:19
            [updated_time] => 2025-06-02 10:40:47
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => GENTIS-launches-advances-obstetrics-and-pediatrics-genetic-testing-methods-at-the-2nd-expanded-nghe-an-obstetrics-and-pediatrics-scientific-conference-2025
            [title] => GENTIS Launches Advanced Obstetrics and Pediatrics Genetic Testing Methods at the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025
            [description] => On May 30–31, GENTIS was honored to accompany the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025 as a sponsor. In addition to offering engaging activities and attractive gifts at its exhibition booth, GENTIS also showcased its most advanced genetic testing solutions in the field of Obstetrics and Pediatrics. The eye-catching GENTIS booth attracted significant interest from many delegates who stopped by to explore and engage with the team.
            [content] => 

At this year’s Obstetrics and Pediatrics event, GENTIS introduced a wide range of advanced genetic testing methods to the conference, including GEN9, 77 IEMs, biotinidase deficiency screening (SLSS), and notably, three new PGT packages: PGT-M for over 100 rare diseases, PGT NEXT, and PGT UPGRADE.
One of the standout features of the PGT-M 100+ test at GENTIS is its ability to detect more than 100 monogenic (single-gene) inherited disorders with high accuracy. By applying next-generation sequencing (NGS) technology in combination with family-specific marker design, PGT-M 100+ can precisely identify even the smallest DNA variants—factors that could potentially lead to disease. This allows the identification of embryos free of disease-causing genes, increasing the chances of a healthy baby. In addition to cutting-edge technology, the PGT-M service at GENTIS is supported by a team of experienced genetic counselors who provide comprehensive guidance before, during, and after testing.
PGT NEXT is a preimplantation genetic screening method that detects aneuploidy across all 24 chromosomes and identifies chromosomal segmental gains or losses. It can also detect embryos with polyploidy or monoploidy—conditions often excluded due to suspected fertilization abnormalities (such as 0PN, 1PN, 2.1PN, 3PN). By analyzing the entire genome with NGS and SNP genotyping, PGT NEXT increases the accuracy of chromosomal abnormality detection and ensures correct kinship identification among embryos in the same batch, thereby minimizing the risk of sample mix-ups due to handling errors.
PGT UPGRADE is an advanced version of preimplantation genetic testing, capable of detecting aneuploidy across all 24 chromosomes and identifying segmental chromosomal abnormalities larger than 5 Mb. Notably, this test can also detect balanced translocations—genetic abnormalities that may be inherited from either parent, which do not necessarily manifest as disease but can affect reproductive health in future generations. PGT UPGRADE provides in-depth genetic information, helping to optimize embryo selection and increasing the chances of successful pregnancy and healthy offspring.
GEN9 is a pre-marital or pre-pregnancy genetic screening test that detects 9 autosomal recessive genetic disorders, including: Alpha-Thalassemia, Beta-Thalassemia, G6PD deficiency, Phenylketonuria, Galactose metabolism disorder, Citrin deficiency-related jaundice, Pompe disease, Wilson disease, 5-alpha reductase deficiency type 2, and Fabry disease. GEN9 evaluates the risk of parents passing on genetic disorders to their children and provides reproductive support to eliminate disease-causing genes.
The 77 IEMs and SLSS biotinidase deficiency tests are two critical newborn screening methods performed shortly after birth to detect congenital disorders early. The 77 IEMs test identifies over 70 different metabolic disorders, including amino acid, fatty acid, and organic acid metabolism disorders. Meanwhile, the SLSS test detects biotinidase deficiency, a vital enzyme in biotin metabolism. Both tests play an essential role in identifying conditions that may not present obvious symptoms initially. Early diagnosis allows timely medical intervention, reducing the risk of severe complications and improving newborn health outcomes.

The GENTIS exhibition booth attracted significant attention from delegates and attendees. At the booth, doctors’ questions regarding GENTIS genetic testing services were thoroughly and clearly addressed. Notably, healthcare professionals expressed high appreciation for GENTIS’s genetic testing solutions in the field of obstetrics and pediatrics.
Through this event, GENTIS hopes to continue partnering with doctors, specialists, hospitals, and clinics on the journey to make accurate, timely genetic testing more accessible to Vietnamese people. With a mission to contribute to improving the physical and intellectual well-being of the Vietnamese population, GENTIS is committed to continuously updating, researching, and developing genetic testing services to enhance the quality of screening and healthcare in the community.

            [content_more] => 
            [meta_title] => 
            [meta_description] => On May 30–31, GENTIS was honored to accompany the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025 as a sponsor.
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1317
            [category_id] => 4
        )

)